$1.99 Billion is the total value of Nantahala Capital Management's 124 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 27.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | Sell | ISHARES TRput | $423,400,000 | -23.6% | 2,500,000 | -7.4% | 21.23% | -13.4% |
LLY | New | LILLY ELI & COput | $113,480,000 | – | 350,000 | +100.0% | 5.69% | – |
ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $109,162,000 | -24.6% | 2,007,385 | -6.6% | 5.47% | -14.6% |
QURE | Buy | UNIQURE NV | $57,612,000 | +13.4% | 3,090,757 | +9.9% | 2.89% | +28.5% |
SGMS | Sell | LIGHT & WONDER INC | $52,222,000 | -22.3% | 1,111,338 | -2.9% | 2.62% | -12.0% |
SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $51,238,000 | +9.5% | 2,663,087 | -1.1% | 2.57% | +24.1% |
COST | New | COSTCO WHSL CORP NEWput | $47,928,000 | – | 100,000 | +100.0% | 2.40% | – |
IMAX | Buy | IMAX CORP | $46,100,000 | -8.7% | 2,729,441 | +2.3% | 2.31% | +3.4% |
MLHR | Buy | MILLERKNOLL INC | $44,862,000 | -20.0% | 1,707,739 | +5.2% | 2.25% | -9.3% |
TA | TRAVELCENTERS OF AMERICA INC | $43,865,000 | -19.8% | 1,272,570 | 0.0% | 2.20% | -9.1% | |
CDXS | Buy | CODEXIS INC | $43,096,000 | -38.2% | 4,120,098 | +21.8% | 2.16% | -30.0% |
CASH | Buy | META FINL GROUP INC | $38,108,000 | -20.2% | 985,459 | +13.3% | 1.91% | -9.6% |
TNL | Buy | TRAVEL PLUS LEISURE CO | $37,860,000 | -24.7% | 975,281 | +12.4% | 1.90% | -14.6% |
IMAX | IMAX CORPcall | $37,011,000 | -10.8% | 2,191,300 | 0.0% | 1.86% | +1.1% | |
DXPE | Buy | DXP ENTERPRISES INC | $36,910,000 | +14.6% | 1,205,031 | +1.3% | 1.85% | +29.9% |
TNL | TRAVEL PLUS LEISURE COcall | $35,679,000 | -33.0% | 919,100 | 0.0% | 1.79% | -24.1% | |
LXFR | Buy | LUXFER HOLDINGS PLC | $35,196,000 | -6.2% | 2,327,801 | +4.3% | 1.76% | +6.4% |
AMPH | AMPHASTAR PHARMACEUTICALS INput | $34,790,000 | -3.1% | 1,000,000 | 0.0% | 1.74% | +9.9% | |
COST | New | COSTCO WHSL CORP NEW | $34,266,000 | – | 71,495 | +100.0% | 1.72% | – |
ATGE | Buy | ADTALEM GLOBAL ED INCput | $32,373,000 | +117.9% | 900,000 | +80.0% | 1.62% | +147.0% |
RMR | Buy | RMR GROUP INCcl a | $27,517,000 | -8.0% | 970,623 | +0.9% | 1.38% | +4.3% |
IMTX | Buy | IMMATICS N.V | $27,191,000 | +15.6% | 3,121,759 | +6.0% | 1.36% | +31.0% |
KROS | Buy | KEROS THERAPEUTICS INC | $25,196,000 | -43.3% | 911,901 | +11.6% | 1.26% | -35.7% |
RDVT | Buy | RED VIOLET INC | $24,595,000 | -31.6% | 1,291,771 | +2.4% | 1.23% | -22.5% |
SYK | Buy | STRYKER CORPORATIONput | $23,872,000 | +31.9% | 120,000 | +77.3% | 1.20% | +49.4% |
DRI | Buy | DARDEN RESTAURANTS INCput | $22,624,000 | +70.2% | 200,000 | +100.0% | 1.13% | +92.9% |
PTON | Buy | PELOTON INTERACTIVE INC | $22,481,000 | +44.1% | 2,448,878 | +314.8% | 1.13% | +63.3% |
DHX | Buy | DHI GROUP INC | $20,568,000 | -10.2% | 4,138,483 | +7.6% | 1.03% | +1.8% |
PAYA | Sell | PAYA HOLDINGS INC | $19,445,000 | -19.3% | 2,959,599 | -28.0% | 0.98% | -8.5% |
GDEN | Sell | GOLDEN ENTMT INC | $19,181,000 | -52.2% | 484,974 | -29.8% | 0.96% | -45.8% |
RH | New | RH | $19,103,000 | – | 90,000 | +100.0% | 0.96% | – |
HLF | Buy | HERBALIFE NUTRITION LTDcall | $17,744,000 | +118.3% | 867,700 | +224.1% | 0.89% | +147.2% |
MAX | Buy | MEDIAALPHA INCcl a | $16,160,000 | +123.2% | 1,640,624 | +275.0% | 0.81% | +153.1% |
ALTG | Sell | ALTA EQUIPMENT GROUP INC | $15,003,000 | -32.8% | 1,672,545 | -7.4% | 0.75% | -23.9% |
QURE | Sell | UNIQURE NVcall | $14,912,000 | -7.3% | 800,000 | -10.1% | 0.75% | +5.1% |
AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $14,554,000 | -19.7% | 5,142,855 | +18.3% | 0.73% | -9.0% |
APEN | Sell | APOLLO ENDOSURGERY INC | $13,589,000 | -39.7% | 3,723,010 | -0.1% | 0.68% | -31.7% |
LYRA | New | LYRA THERAPEUTICS INC | $13,389,000 | – | 2,369,668 | +100.0% | 0.67% | – |
RDI | Sell | READING INTL INCcl a | $11,578,000 | -16.2% | 3,207,247 | -0.6% | 0.58% | -4.9% |
AMYT | Buy | AMRYT PHARMA PLCsponsored ads | $10,922,000 | +23.2% | 1,562,458 | +45.8% | 0.55% | +39.8% |
Buy | DARIOHEALTH CORP | $10,627,000 | +6.0% | 1,730,810 | +0.9% | 0.53% | +20.3% | |
PTON | Buy | PELOTON INTERACTIVE INCcall | $10,452,000 | -55.5% | 1,138,600 | +28.1% | 0.52% | -49.6% |
BBQ | Sell | BBQ HLDGS INC | $9,881,000 | -31.4% | 948,254 | -0.3% | 0.50% | -22.3% |
SMLR | Sell | SEMLER SCIENTIFIC INC | $9,767,000 | -44.8% | 346,606 | -2.9% | 0.49% | -37.4% |
IIII | Sell | INSU ACQUISITION CORP III | $9,655,000 | -1.2% | 980,183 | -1.5% | 0.48% | +12.0% |
VMD | Buy | VIEMED HEALTHCARE INC | $9,226,000 | +43.2% | 1,714,926 | +32.5% | 0.46% | +62.5% |
Sell | ARYA SCIENCES ACQUISITN CORP | $8,384,000 | -0.5% | 862,566 | -0.4% | 0.42% | +12.6% | |
GOGO | New | GOGO INCput | $8,095,000 | – | 500,000 | +100.0% | 0.41% | – |
RNG | New | RINGCENTRAL INCcl a | $7,839,000 | – | 150,000 | +100.0% | 0.39% | – |
CBAY | Buy | CYMABAY THERAPEUTICS INC | $7,801,000 | +32.4% | 2,644,306 | +39.6% | 0.39% | +49.8% |
HERA | Sell | FTAC HERA ACQUISITION CORP | $7,714,000 | -1.5% | 787,130 | -1.6% | 0.39% | +11.5% |
FBIO | Sell | FORTRESS BIOTECH INC | $7,356,000 | -38.8% | 8,758,648 | -0.9% | 0.37% | -30.6% |
CNCE | New | CONCERT PHARMACEUTICALS INC | $6,988,000 | – | 1,659,840 | +100.0% | 0.35% | – |
PAR TECHNOLOGY CORPnote 2.875% 4/1 | $6,675,000 | -4.0% | 5,785,000 | 0.0% | 0.34% | +8.8% | ||
SRL | Sell | SCULLY ROYALTY LTD | $6,189,000 | -18.4% | 771,196 | -0.2% | 0.31% | -7.7% |
TSHA | Buy | TAYSHA GENE THERAPIES INC | $6,114,000 | -29.7% | 1,643,438 | +23.2% | 0.31% | -20.3% |
PRDO | New | PERDOCEO ED CORPput | $5,890,000 | – | 500,000 | +100.0% | 0.30% | – |
SBTX | Buy | SILVERBACK THERAPEUTICS INC | $5,877,000 | +86.5% | 1,386,138 | +51.7% | 0.30% | +112.2% |
APEN | New | APOLLO ENDOSURGERY INCcall | $5,840,000 | – | 1,600,000 | +100.0% | 0.29% | – |
ONTF | Buy | ON24 INC | $5,413,000 | +7.2% | 570,403 | +48.5% | 0.27% | +21.5% |
Sell | APTOSE BIOSCIENCES INC | $5,367,000 | -46.1% | 7,232,676 | -1.2% | 0.27% | -39.0% | |
CBIO | Buy | CATALYST BIOSCIENCES INC | $4,906,000 | +207.0% | 2,755,903 | +13.8% | 0.25% | +246.5% |
Buy | AURA BIOSCIENCES INC | $4,863,000 | -26.8% | 343,215 | +13.7% | 0.24% | -17.0% | |
SYK | New | STRYKER CORPORATION | $4,575,000 | – | 23,000 | +100.0% | 0.23% | – |
SSKN | STRATA SKIN SCIENCES INC | $4,397,000 | -34.6% | 4,575,812 | 0.0% | 0.22% | -26.2% | |
IWM | Sell | ISHARES TRrussell 2000 etf | $4,043,000 | -94.6% | 23,873 | -93.5% | 0.20% | -93.9% |
CRIS | Buy | CURIS INC | $3,572,000 | -39.4% | 3,628,162 | +46.4% | 0.18% | -31.4% |
INMD | New | INMODE LTD | $3,544,000 | – | 158,154 | +100.0% | 0.18% | – |
Sell | AVALO THERAPEUTICS INC | $3,355,000 | -30.2% | 6,710,327 | -2.0% | 0.17% | -21.1% | |
Sell | AKUMIN INC | $3,325,000 | -46.3% | 5,545,233 | -0.6% | 0.17% | -39.1% | |
RILY | Sell | B. RILEY FINANCIAL INC | $3,257,000 | -40.7% | 77,083 | -1.8% | 0.16% | -32.9% |
ARYD | Sell | ARYA SCIENCES ACQU CORP IVcl a | $3,168,000 | -0.8% | 322,929 | -0.9% | 0.16% | +12.8% |
BRPM | Sell | B RILEY PRINCIPAL 150 MERGER | $2,965,000 | -1.0% | 297,727 | -1.3% | 0.15% | +12.9% |
RMBL | New | RUMBLEON INC | $2,942,000 | – | 200,000 | +100.0% | 0.15% | – |
MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $2,924,000 | -10.6% | 491,509 | -4.9% | 0.15% | +1.4% |
PWP | PERELLA WEINBERG PARTNERS | $2,931,000 | -38.3% | 502,676 | 0.0% | 0.15% | -30.0% | |
STIM | Sell | NEURONETICS INC | $2,463,000 | -7.6% | 767,400 | -12.8% | 0.12% | +5.1% |
KR | New | KROGER COcall | $2,366,000 | – | 50,000 | +100.0% | 0.12% | – |
NPCE | Sell | NEUROPACE INC | $2,368,000 | -40.6% | 478,438 | -1.4% | 0.12% | -32.4% |
CDTX | Sell | CIDARA THERAPEUTICS INC | $2,355,000 | -42.9% | 4,819,090 | -2.7% | 0.12% | -35.5% |
IMTXW | IMMATICS N.V*w exp 07/01/202 | $2,113,000 | +21.4% | 1,035,613 | 0.0% | 0.11% | +37.7% | |
NAUT | Sell | NAUTILUS BIOTECHNOLOGY INC | $2,111,000 | -45.6% | 784,798 | -12.2% | 0.11% | -38.4% |
AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $1,958,000 | -73.4% | 3,877,311 | +21.1% | 0.10% | -69.9% |
VRM | VROOM INCcall | $1,875,000 | -53.0% | 1,500,000 | 0.0% | 0.09% | -46.9% | |
SFT | Sell | SHIFT TECHNOLOGIES INCcl a | $1,792,000 | -78.2% | 2,662,933 | -28.6% | 0.09% | -75.2% |
SLNO | SOLENO THERAPEUTICS INC | $1,675,000 | -20.4% | 9,436,512 | 0.0% | 0.08% | -9.7% | |
ZVO | Sell | ZOVIO INC | $1,606,000 | -25.1% | 1,655,335 | -36.7% | 0.08% | -14.7% |
FVAM | Sell | 5 01 ACQUISITION CORP | $1,554,000 | -2.9% | 157,044 | -3.3% | 0.08% | +9.9% |
PAYO | PAYONEER GLOBAL INC | $1,511,000 | -12.1% | 385,366 | 0.0% | 0.08% | 0.0% | |
IDWM | Sell | IDW MEDIA HLDGS INCcl b | $1,411,000 | -31.1% | 1,052,852 | -5.9% | 0.07% | -22.0% |
ANGN | Sell | ANGION BIOMEDICA CORP | $1,289,000 | -48.2% | 1,131,001 | -3.6% | 0.06% | -40.9% |
Sell | HYPERFINE INC | $1,215,000 | -42.5% | 544,930 | -8.6% | 0.06% | -34.4% | |
KROS | KEROS THERAPEUTICS INCcall | $1,158,000 | -49.2% | 41,900 | 0.0% | 0.06% | -42.6% | |
IMAC | Sell | IMAC HLDGS INC | $1,044,000 | -54.8% | 1,259,379 | -43.8% | 0.05% | -49.0% |
LVTX | Sell | LAVA THERAPEUTICS NV | $953,000 | -35.2% | 322,980 | -3.3% | 0.05% | -26.2% |
ALEC | Sell | ALECTOR INC | $937,000 | -30.6% | 92,176 | -2.7% | 0.05% | -21.7% |
IMV | Sell | IMV INC | $933,000 | -64.6% | 1,424,676 | -23.7% | 0.05% | -59.5% |
ACER | Sell | ACER THERAPEUTICS INC | $934,000 | -58.6% | 741,010 | -4.7% | 0.05% | -53.0% |
FARADAY FUTRE INTLGT ELCTR I | $910,000 | -47.9% | 350,000 | 0.0% | 0.05% | -40.3% | ||
Sell | HELIOGEN INC | $916,000 | -72.9% | 433,909 | -32.6% | 0.05% | -69.3% | |
XGN | Sell | EXAGEN INC | $896,000 | -29.9% | 156,135 | -2.0% | 0.04% | -21.1% |
EAR | New | EARGO INC | $774,000 | – | 1,028,965 | +100.0% | 0.04% | – |
Sell | LUCID DIAGNOSTICS INC | $698,000 | -34.2% | 308,978 | -2.0% | 0.04% | -25.5% | |
Buy | UNICYCIVE THERAPEUTICS INC | $606,000 | -26.6% | 729,680 | +13.9% | 0.03% | -18.9% | |
CDXS | New | CODEXIS INCcall | $523,000 | – | 50,000 | +100.0% | 0.03% | – |
Sell | COGNITION THERAPEUTICS INC | $407,000 | -24.6% | 192,752 | -1.9% | 0.02% | -16.7% | |
Sell | IN8BIO INC | $359,000 | -70.7% | 148,801 | -57.8% | 0.02% | -66.7% | |
MILE | Sell | METROMILE INC | $298,000 | -78.4% | 325,002 | -68.9% | 0.02% | -75.4% |
TACT | Sell | TRANSACT TECHNOLOGIES INC | $279,000 | -44.6% | 69,991 | -1.9% | 0.01% | -36.4% |
CUE | Sell | CUE BIOPHARMA INC | $250,000 | -97.7% | 100,464 | -95.5% | 0.01% | -97.3% |
PWPPW | PERELLA WEINBERG PARTNERS*w exp 12/31/202 | $264,000 | -67.9% | 409,128 | 0.0% | 0.01% | -63.9% | |
Sell | WEJO GROUP LIMITED | $158,000 | -81.6% | 132,728 | -38.3% | 0.01% | -78.9% | |
New | SITIO ROYALTIES CORP*w exp 08/23/202 | $93,000 | – | 582,350 | +100.0% | 0.01% | – | |
HERAW | FTAC HERA ACQUISITION CORP*w exp 02/28/202 | $53,000 | -45.4% | 222,949 | 0.0% | 0.00% | -25.0% | |
MILEW | METROMILE INC*w exp 02/09/202 | $57,000 | -13.6% | 507,460 | 0.0% | 0.00% | 0.0% | |
BRPMW | Buy | B RILEY PRINCIPAL 150 MERGER*w exp 03/01/202 | $69,000 | -36.7% | 185,653 | +53.8% | 0.00% | -40.0% |
TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $56,000 | -52.1% | 235,294 | 0.0% | 0.00% | -40.0% | ||
Sell | FINTECH ACQUISITION CORP VI*w exp 03/31/202 | $39,000 | -72.7% | 240,600 | -3.8% | 0.00% | -66.7% | |
FTCVW | FINTECH ACQUISITION CORP V*w exp 12/31/202 | $30,000 | -90.5% | 333,331 | 0.0% | 0.00% | -85.7% | |
IIIIW | INSU ACQUISITION CORP III*w exp 12/31/202 | $30,000 | -55.2% | 333,332 | 0.0% | 0.00% | -33.3% | |
KTRA | Sell | KINTARA THERAPEUTICS INC | $32,000 | -87.9% | 116,234 | -82.5% | 0.00% | -83.3% |
RFL | New | RAFAEL HLDGS INC | $36,000 | – | 19,435 | +100.0% | 0.00% | – |
QUALTEK SERVICES INC*w exp 02/14/202 | $15,000 | -73.2% | 96,244 | 0.0% | 0.00% | -50.0% | ||
Sell | GUARDFORCE AI CO LTD*w exp 10/01/202 | $19,000 | -86.6% | 154,205 | -58.8% | 0.00% | -83.3% | |
OCGN | Exit | OCUGEN INC | $0 | – | -16,571 | -100.0% | -0.00% | – |
Exit | FALCON MINERALS CORP*w exp 07/21/202 | $0 | – | -674,561 | -100.0% | -0.01% | – | |
HTGM | Exit | HTG MOLECULAR DIAGNOSTICS IN | $0 | – | -285,963 | -100.0% | -0.02% | – |
GLMD | Exit | GALMED PHARMACEUTICALS LTD | $0 | – | -258,957 | -100.0% | -0.02% | – |
ELOX | Exit | ELOXX PHARMACEUTICALS INC | $0 | – | -774,767 | -100.0% | -0.02% | – |
AKBA | Exit | AKEBIA THERAPEUTICS INCcall | $0 | – | -965,800 | -100.0% | -0.03% | – |
Exit | TANGO THERAPEUTICS INC | $0 | – | -98,794 | -100.0% | -0.03% | – | |
WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -819,101 | -100.0% | -0.07% | – |
PAYA | Exit | PAYA HOLDINGS INCcall | $0 | – | -300,000 | -100.0% | -0.08% | – |
W | Exit | WAYFAIR INCcl a | $0 | – | -34,688 | -100.0% | -0.17% | – |
KURA | Exit | KURA ONCOLOGY INCcall | $0 | – | -240,900 | -100.0% | -0.17% | – |
HCA | Exit | HCA HEALTHCARE INC | $0 | – | -35,600 | -100.0% | -0.40% | – |
FTCV | Exit | FINTECH ACQUISITION CORP V | $0 | – | -958,137 | -100.0% | -0.42% | – |
Exit | FINTECH ACQUISITION CORP VI | $0 | – | -999,992 | -100.0% | -0.43% | – | |
XBI | Exit | SPDR SER TRput | $0 | – | -250,000 | -100.0% | -0.99% | – |
IMXI | Exit | INTERNATIONAL MNY EXPRESS IN | $0 | – | -1,425,985 | -100.0% | -1.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 42 | Q3 2023 | 27.2% |
CODEXIS INC | 42 | Q3 2023 | 3.9% |
PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
QAD INC | 32 | Q3 2021 | 2.6% |
SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-03-21 |
4 | 2024-03-15 |
SC 13G | 2024-03-11 |
13F-HR/A | 2024-02-15 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.